What is the standard treatment for Tuberculosis (TB)?

The standard treatment for Tuberculosis (TB) is Isoniazid (INH). Isoniazid is a first-line antitubercular agent that is specifically effective against Mycobacterium tuberculosis, the bacterium that causes TB. It works by inhibiting the synthesis of mycolic acids, which are essential components of the bacterial cell wall. This action leads to the death of the bacteria, making it a key drug in the treatment regimen.

Standard treatment typically involves a combination of medications to ensure effective results and minimize the risk of developing drug-resistant strains. Isoniazid is often used alongside other first-line drugs such as rifampicin, pyrazinamide, and ethambutol during the intensive phase of treatment.

This approach not only targets the bacteria effectively but also helps in preventing relapse and promotes better health outcomes for patients. The use of Isoniazid has been well-established through clinical guidelines and recommendations from health organizations, solidifying its role as a cornerstone in TB treatment.